Wear2B

Noninvasive Blood Glucose Monitoring

Health Tech & Life Sciences
Private

Company Overview

Snapshot

Founded in November 2015 by Ohad Bashan, Wear2B operates with 1–10 employees. The company is currently in the Pre-Funding stage, developing a patented solution for noninvasive, continuous, real-time monitoring of blood-related health parameters.

Business overview

Wear2B is a Health Tech & Life Sciences company focused on developing a patented solution for noninvasive, continuous, real-time monitoring of blood-related health parameters, such as blood glucose levels. Leveraging artificial intelligence and machine learning, the company's core technology is applied in the digital healthcare and digital therapeutics sectors, serving the global market with a B2B2C business model.

Company Intelligence Q&A

What is Wear2B's primary focus?
Wear2B is developing a patented solution for noninvasive, continuous, real-time monitoring of blood-related health parameters, including blood glucose levels.
When was Wear2B founded?
Wear2B was founded in November 2015.
Who is the founder of Wear2B?
Ohad Bashan is the founder of Wear2B.
What is the current product stage of Wear2B's solution?
Wear2B's solution is currently in the Clinical Trial stage, indicating it is undergoing testing and evaluation in a clinical setting.
What business model does Wear2B employ?
Wear2B operates on a B2B2C business model, targeting global markets.